The flu season 2026/7 will soon be upon us. Egg allergy is common, and the safety of providing this vaccine to egg-allergic individuals is always a concern for parents and some healthcare providers. We receive a significant amount of correspondence on this topic in our London Allergy Consults practice.

Historical anxieties around egg-based vaccine manufacturing have frequently caused unnecessary hesitation, making evidence-based reassurance essential as the annual immunisation rollout approaches. Helpful guidelines are available; we have summarised them here: Current scientific consensus from the UK Health Security Agency (UKHSA) Green Book, the British Society for Allergy and Clinical Immunology (BSACI), and paediatric guidelines confirm that the overwhelming majority of egg-allergic patients can be safely vaccinated. Indeed, in our practice, we have not encountered significant reactions in egg-allergic patients using the recommended UK vaccines each year.

1. UK Flu Vaccine Products and Licensed Ages

Influenza vaccines use different manufacturing substrates, categorised primarily as egg-derived or using alternative technologies.

Live Attenuated Influenza Vaccine (LAIV / Fluenz): This is the standard vaccine in the UK for children, and is administered intranasally as a nasal spray.
- Licensed Age: 24 months to under 18 years of age.
Inactivated Egg-Cultured Quadrivalent/Trivalent Vaccines (IIV): Widely used across adult and some paediatric cohorts. While manufactured using egg proteins, trace amounts rarely trigger systemic allergic reactions, and these vaccines have an excellent safety record.
- Licensed Age: Varies by specific product brand, but collectively available for cohorts ranging from 6 months of age onwards through adulthood and older age groups.
Cell-Based Inactivated Vaccines (QIVc): Grown in mammalian cell lines rather than eggs. While not universally mandated as a primary tool solely for egg allergy mitigation given the safety of standard vaccines, they present an alternative when indicated.
- Licensed Age: Typically licensed for individuals from 2 years of age onwards (depending on the specific marketing authorisation).

2. Contraindications and Allergy Guidelines: Green Book, BSACI, and Paediatric Standards

Aligning with the UKHSA Green Book (Chapter 19) and BSACI guidelines, the clinical position on egg allergy and influenza immunisation is clear:

General Rule:
- An egg allergy is not a general contraindication for the annual influenza vaccines in the UK.
The Only Absolute Contraindication: The sole exception is a confirmed history of a severe systemic anaphylactic reaction (requiring intensive care support) to a previous dose of an influenza vaccine itself, or hypersensitivity to an active vaccine component (other than ovalbumin) or excipient. Both these clinical criteria are exceptionally rare.
Anaphylaxis and Asthma History: Even children and adults with a history of severe anaphylaxis to dietary egg can safely receive routine inactivated injectable flu vaccines and the nasal LAIV spray in primary care settings. Specialist hospital referral is not routinely required solely because of an egg allergy.
The Rare Exception: The only scenario requiring specialist allergy input is if a patient has experienced severe systemic anaphylaxis to a previous dose of an influenza vaccine.

3. Optimising Patient Care and Reassurance

The safety profile of modern influenza vaccines means that withholding the vaccine poses a significantly higher clinical risk of severe influenza morbidity than the negligible risk of an allergic reaction.

However, navigating complex food allergies alongside medical interventions can sometimes feel overwhelming, particularly for parents managing children with multiple atopic conditions, and often with concomitant asthma (the allergic march starts with eczmea, then food allergies may develop and then hayfever and asthma may devlop).

Consult With Us at London Allergy Consultants

If you or your child have a complex medical history, severe systemic reactions, or if you remain anxious about navigating this season's immunisation rollout, our team at London Allergy Consultants offers expert clinical evaluations to provide clarity, tailored advice, and absolute peace of mind. Tel - 0330 678 5168